Where’s there’s smoke there’s fire.., page-82

I believe that the near term news flow should also offer some push to the SP. I have been looking into quite a few of these recent biotechs that have popped and of them all I believe LCT has the nearest term significant announcement yet it hasn’t run nearly as much as the others have or with the same frequent high volume days, a few of these other companies are still many months away from their next significant announcements yet continue to run.
Perhaps it is more risky as the last results in November didn’t live up to expectations and our market cap isn’t as cheap as some of our peers... but looking at their interpretation of data from the May follow up it seems more likely this time that we might achieve a statistically significant clinical difference this time around at the 18 month mark, which should then hopefully flow onto the 24 month follow up.

I have entered over the past few days with a decent parcel and will wait for the announcement in the next couple of weeks to reasses.